Regeneron Pharmaceuticals, Inc.

Symbol: REGN

NASDAQ

957

USD

Markedspris i dag

26.7418
P/E-forhold
0.3008
PEG Ratio
103.71B
MRK Cap
0.00%
DIV Udbytte

Regeneron Pharmaceuticals, Inc. (REGN) Årsregnskaber

Q: Hvad er Regeneron Pharmaceuticals, Inc. (REGN) samlede aktiver?

Regeneron Pharmaceuticals, Inc. (REGN) samlede aktiver er .

Q: Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er .

Download

Årlig Kvartalsvis

Lineær Log

På diagrammet kan du se standardtallene i dynamik for Regeneron Pharmaceuticals, Inc. (REGN). Virksomhedens omsætning viser gennemsnittet af 2585.271 M, som er 0.382 % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er 2297.251 M, som er 0.359 %. Den gennemsnitlige bruttofortjeneste er 0.827 %. Væksten i nettoindkomst for virksomheden sidste år er -0.089 %, hvilket svarer til -0.111 % % i gennemsnit for hele virksomhedens historie.,

Årlig Kvartalsvis

10Y 20Y 30Y 40Y

Balance

Når vi dykker ned i den skattemæssige udvikling for Regeneron Pharmaceuticals, Inc., ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til 0. Et kig tilbage på det seneste år afslører en samlet aktivændring på 0.132. Når det gælder omsætningsaktiver, er REGN på 19479.2 i rapporteringsvalutaen. En betydelig del af disse aktiver, helt præcist 10844.8, ligger i kontanter og kortfristede investeringer. Dette segment viser en ændring på -0.243%, når det sammenlignes med sidste års data. Virksomhedens langsigtede investeringer, som ikke er dens fokus, ligger på 5396.5, hvis nogen, i rapporteringsvalutaen. Dette indikerer en forskel på -0.183% fra den sidste rapporteringsperiode, hvilket afspejler virksomhedens strategiske skift. Virksomhedens gældsprofil viser en samlet langfristet gæld på 2702.9 i rapporteringsvalutaen. Dette tal betyder en ændring fra år til år på 0.001%. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til 25973.1 i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er 0.146%. Et dybere dyk ned i virksomhedens økonomi afslører yderligere detaljer. Nettotilgodehavenderne er vurderet til 5667.3, med en værdiansættelse af varelageret på 2580.5 og goodwill vurderet til 0, hvis der er nogen. De samlede immaterielle aktiver, hvis de findes, værdiansættes til 1038.6.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992	1990
balance-sheet.row.cash-and-short-term-investments	40205.6	10844.8	14334.1	12532.7	6722.6	6471.1	4564.9	2896.1	1902.9	1677.4	1360.6	1083.9	587.5	526.9	626.9	341.3	474.8	766.5	459.3	298.5	296	293.8	264.3	385.1	117.6	66.2	19.8	28.9	34.5	32.7	23.6	12.5	16.4	26.2	21.8
balance-sheet.row.short-term-investments	30784.1	8114.8	4636.4	2809.1	1393.3	1596.5	1342.2	596.8	503.5	236.1	251.8	158.4	77.8	43.3	136.8	134.3	227	267.5	221.4	114	194.7	175.5	184.2	137.7	86.6	42.5	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	21595.3	5667.3	5328.7	6036.5	4114.7	2672.2	2243.2	1974.3	1611.6	1467.8	1017.4	891.8	693.1	103	93.1	65.6	35.2	18.3	7.5	36.5	43.1	15.5	4	3	13.8	0.6	5.7	6.6	4.3	2.7	1.7	1.7	1.1	1.4	0.2
balance-sheet.row.inventory	9865.6	2580.5	2401.9	1951.3	1916.6	1415.5	1151.2	726.1	399.4	238.6	128.9	70.4	28.6	13.6	-15.1	0	0	0	0	2.9	3.2	9	6.8	4	1.9	4.6	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	1737	386.6	933	332.4	1164	959.3	243.3	225	130.5	163.5	120.7	140.8	176.2	810.5	15.1	18.6	11.5	13.1	3.2	3.4	1.6	1.9	1.8	2.2	0.8	1.6	67.4	64.1	46.2	13.8	26.7	77.6	67.2	79	0.4
balance-sheet.row.total-current-assets	73908.5	19479.2	22064.7	20520.5	12753.9	10558.8	7959.3	5596.6	3913.9	3383.8	2506.9	2252.2	1620.8	913.6	720.1	425.5	521.4	797.8	470	341.4	344	320.2	276.9	394.2	134.1	73	92.9	99.6	85	49.2	52	91.8	84.7	106.6	22.4
balance-sheet.row.property-plant-equipment-net	16300.6	4146.4	3763	3482.2	3221.6	2890.4	2575.8	2358.6	2083.4	1594.1	974.3	527	379.9	368	347.4	259.7	87.9	58.3	49.4	60.5	71.2	80.7	76.8	39.4	36.9	36.3	33	32.7	34.3	27.9	27.7	22.4	10.5	5.4	2.2
balance-sheet.row.goodwill	0	0	0	-6844.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	4067.5	1038.6	915.5	6.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.5
balance-sheet.row.goodwill-and-intangible-assets	4067.5	1038.6	915.5	-6838	-3135.6	-3256.8	-1755	-1486.5	-864.3	-632.2	-460.2	-621.8	-463.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.5
balance-sheet.row.long-term-investments	24562.5	5396.5	5406.4	6838	3135.6	3256.8	1755	1486.5	864.3	632.2	460.2	389.9	271.2	275.9	370.1	47.1	51.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	9795.6	2575.4	1723.7	876.9	858.9	824.2	828.7	506.3	825.3	461.9	316.1	231.9	192	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	1635.9	444.1	-4658.8	555.2	328.9	531.8	370.7	302.8	150.8	169.3	74.5	171.8	79.8	-233.8	-348.1	8.9	9.7	80.1	65.8	21.6	57.9	78.6	37.8	61.8	37.2	27.7	31	36.1	18.3	16.7	14.5	3.4	2.7	0.4	0.3
balance-sheet.row.total-non-current-assets	56362.1	13601	7149.8	4914.3	4409.4	4246.4	3775.2	3167.7	3059.5	2225.4	1364.9	698.8	459.7	410	369.4	315.7	148.6	138.4	115.1	82.1	129.2	159.3	114.6	101.2	74.1	64	64	68.8	52.6	44.6	42.2	25.8	13.2	7.4	3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	130270.6	33080.2	29214.5	25434.8	17163.3	14805.2	11734.5	8764.3	6973.5	5609.1	3871.8	2951	2080.5	1323.6	1089.4	741.2	670	936.3	585.1	423.5	473.1	479.6	391.6	495.4	208.3	137	156.9	168.4	137.6	93.8	94.2	117.6	97.9	114	25.4
balance-sheet.row.account-payables	2361.8	606.6	589.2	564	475.5	418.1	218.2	178.2	135	141	99.5	61.9	38.9	27.7	-48	18.6	6.3	8.1	21.5	23.3	18.9	18.9	30.3	14.8	9.4	6.6	5.6	4.7	4.4	6.3	5	10.3	2.5	1.6	0
balance-sheet.row.short-term-debt	0	0	720	719.7	1631.2	0	-90.8	468.8	127.3	452.6	350.2	0.9	1.4	1	0.7	0	-162.4	202.3	-21.5	-23.3	-18.9	13.8	0.1	0.4	0.6	1.4	1.1	1.8	3.6	3.5	3.1	1.6	1	0.4	0
balance-sheet.row.tax-payables	0	0	0.3	326.3	19.5	49.4	20.8	0.2	235.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	10091	2702.9	2701.4	2699.7	2695.7	713.9	708.5	703.5	481.1	375.5	459.1	505.5	457.3	435.5	160	0	5.1	0	200	200	200	200	200	200.2	2.1	2.7	3.1	3.8	5.1	6	9.2	5.9	5.8	2.4	0
Deferred Revenue Non Current	554	126.7	69.8	515.3	635.5	1210.7	916.7	949.3	1062.4	818.2	250.3	231.2	259.2	248.6	340.6	137.9	162.4	0	123.5	69.1	56.4	68.8	5.5	6.9	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	770.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	9571.5	2357.9	1992.2	1725.3	122.4	781.1	772.1	0.3	486.7	13.6	96.4	152.4	27.5	73.3	53.7	30.4	29.9	28.8	21.5	23.3	18.9	0	0	0	3.7	5.3	2.7	4.2	4	3.1	9.8	1.2	1.1	1.3	0
balance-sheet.row.total-non-current-liabilities	14676.8	3683.7	2701.4	3215	3331.2	1924.6	1625.2	1652.8	1543.6	1193.7	709.4	736.7	716.5	435.5	500.6	250.9	167.5	192.3	323.5	269.1	256.4	269	205.5	207	12.4	14.2	16.3	18.8	18.7	13	9.2	6.1	6.1	4.5	11.4
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	2880	720	720	719.7	717.2	713.9	708.5	703.5	481.1	364.7	312.3	185.2	160.8	160.5	160	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	28384.1	7107.1	6550.5	6666	6138	3715.5	2977.2	2620.2	2524.2	1954.3	1329.5	998.9	835.1	837.9	561.6	344.4	251.2	476	368.5	309.5	290.6	341.9	245.6	229	26.1	27.5	25.7	29.5	30.7	25.9	27.1	19.2	10.7	7.8	13.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	106436.2	27260.3	23306.7	18968.3	10893	7379.8	5254.3	2946.7	1748.2	852.7	255.4	-92.7	-517.1	-1267.3	-1045.6	-941.1	-875.9	-793.2	-687.6	-585.3	-489.8	-531.5	-424.1	-299.7	-223.5	-200.3	-177.2	-168.6	-157	-124.6	-101.1	-70.4	-30.6	-11.4	-7
balance-sheet.row.accumulated-other-comprehensive-income-loss	-532.6	-80.9	-238.8	-26.2	29.3	21.1	-12.3	0.6	-12.8	8.6	52.3	-1.2	-1.2	-1.9	-2.5	1	-0.1	0.2	-0.2	-0.8	-3.1	-4	-3.2	-1.6	-0.8	-0.5	-26.6	-23.6	-5.9	-5.9	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	-4017.5	-1206.4	-404	-173.4	102.9	3688.7	3515.2	3196.6	2713.8	2793.5	2234.6	2045.9	1763.5	1754.8	1575.8	1336.7	1294.8	1253.2	904.4	700	675.4	673.1	573.2	567.6	406.4	310.3	335	331.1	269.8	198.4	168.2	168.8	117.8	117.6	19.2
balance-sheet.row.total-stockholders-equity	101886.5	25973.1	22664	18768.8	11025.3	11089.7	8757.3	6144.1	4449.2	3654.8	2542.3	1952.1	1245.4	485.7	527.8	396.8	418.9	460.3	216.6	114	182.5	137.6	146	266.4	182.1	109.5	131.2	138.9	106.9	67.9	67.1	98.4	87.2	106.2	12.2
balance-sheet.row.total-liabilities-and-stockholders-equity	130270.6	33080.2	29214.5	25434.8	17163.3	14805.2	11734.5	8764.3	6973.5	5609.1	3871.8	2951	2080.5	1323.6	1089.4	741.2	670	936.3	585.1	423.5	473.1	479.6	391.6	495.4	208.3	137	156.9	168.4	137.6	93.8	94.2	117.6	97.9	114	25.4
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	101886.5	25973.1	22664	18768.8	11025.3	11089.7	8757.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	130270.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	45970.9	13511.3	10042.8	9647.1	4528.9	4853.3	3097.2	2083.3	1367.7	868.3	711.9	548.3	349	319.2	506.8	181.3	278	267.5	221.4	114	194.7	175.5	184.2	137.7	86.6	42.5	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	10811	2702.9	2701.4	2699.7	2695.7	713.9	708.5	703.5	481.1	375.5	459.1	505.5	457.3	435.5	160	0	5.1	202.3	200	200	200	213.8	200.2	200.6	2.7	4.1	4.2	5.6	8.7	9.5	12.3	7.5	6.8	2.8	0
balance-sheet.row.net-debt	1389.5	-27.1	-404.5	-185.9	502	-903.9	-759.2	-109.3	-54.1	-433.6	-189.7	-30.1	227.1	-48.1	47.5	-98.1	-242.7	-296.6	-37.9	15.5	98.8	95.5	120.1	-46.8	-28.3	-19.6	-15.6	-23.3	-25.8	-23.2	-11.3	-5	-9.6	-23.4	-21.8

Pengestrømsopgørelse

Det økonomiske landskab for Regeneron Pharmaceuticals, Inc. har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på -0.171. Virksomheden udvidede for nylig sin aktiekapital ved at udstede 1145.5, hvilket markerer en forskel på 0.000 i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på -3185100000.000 i rapporteringsvalutaen. Dette er en forskydning på -0.158 fra året før. I samme periode har virksomheden registreret 421, 0 og 0, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på 0.000, med en forskel fra år til år på 0.000. Desuden afsatte virksomheden 0 til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet -700.6, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992
cash-flows.row.net-income	3857.8	3953.6	4338.4	8075.3	3513.2	2115.8	2444.4	1198.5	895.5	636.1	348.1	424.4	750.3	-221.8	-104.5	-67.8	-82.7	-105.6	-102.3	-95.4	41.7	-107.5	-124.4	-76.2	-23.2	-23.1	-8.6	-11.6	-32.4	-23.5	-30.7	-39.9	-19.1	-4.5
cash-flows.row.depreciation-and-amortization	435.6	421	341.4	286.2	235.9	210.3	148.2	145.5	104.7	74.9	52.7	41.2	36.9	31.1	19.7	14.2	11.3	11.5	14.6	15.5	15.4	12.9	8.5	6.1	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8
cash-flows.row.deferred-income-tax	-811.7	-837.8	-746.4	-147.1	75.6	-130.6	-140	318.8	-360.1	-121.6	-66.6	63.6	-340.2	0	0	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	876.4	885	725	601.7	432	464.3	427.4	507.3	559.9	459	307.2	198.4	94.2	56.1	39.9	31.3	32.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	105.5	-94.1	-243.3	-1916.5	-1503.6	-200.5	-697	-926.5	228.2	229.8	20.2	-190.7	-672.8	-17.5	140.9	-49.5	-52.4	87.5	93	27.8	-58.7	84.3	3.6	11	-15.3	1.2	-7.4	-2.6	-8.5	-14.8	-3	3.1	1.5	-0.6
cash-flows.row.account-receivables	-102.1	-338.8	707.8	-1927.4	-1356.1	-473.1	-268.9	-362.7	-143.8	-491.4	-62.4	-198.7	-590.1	-21.1	-27.5	-30.4	-16.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-380.7	-271.7	-696.5	-494.3	-529.4	-335.5	-387.9	-314.2	-149.8	-111.8	-60.9	-48	-52.6	0	0	-4.6	0	0	3.6	1.3	6.9	-1	-1.7	-0.9	4	-4	0	0	0	0	0	0	0	0
cash-flows.row.account-payables	478.9	598.6	-138.4	866.1	118.9	444.5	210	-23.2	254	303.7	162.2	136.7	11	0	0	13	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	109.4	-82.2	-116.2	-360.9	263	163.6	-250.2	-226.4	267.8	529.4	-18.7	-80.7	-41.1	3.7	168.5	-27.5	-35.5	87.5	89.4	26.5	-65.7	85.4	5.3	12	-19.3	5.2	-7.4	-2.6	-8.5	-14.8	0	0	0	0
cash-flows.row.other-non-cash-items	332.1	266.3	599.8	181.7	-135	-29.3	12.1	-36.9	485.7	619.8	361.6	133.7	-861.8	10.4	0.3	-0.4	2.2	34	17.9	21.9	-15.2	4.1	1.8	1.8	6.1	4.7	2.8	3.7	14.5	14.2	9	3.6	-1.6	-2.5
cash-flows.row.net-cash-provided-by-operating-activities	4738.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-764.3	-926.4	-590.1	-551.9	-614.6	-429.6	-383.1	-272.6	-511.9	-677.9	-333	-156.3	-49.3	-57.2	-99.7	-97.3	-34.9	-18.4	-2.8	-5	-6.2	-29.7	-34.4	-8.2	-6.5	-5.7	-3	-2.1	-8.6	-3.3	-6.9	-10.2	-2.1	-1
cash-flows.row.acquisitions-net	330	-54.9	-230.3	551.9	614.6	429.6	1069.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-15554.1	-11646	-7487.9	-7048.1	-3241	-3202.4	-1845.5	-1277.1	-809.4	-557.1	-564.2	-577.3	-470.4	-240.4	-612.2	-200	-581.1	-594.4	-456.9	-103	-276.3	-287.5	-240	-191.4	-104.9	-60.1	-88	-112.6	-74.6	-28.1	-22.5	-77.3	-71.6	-137.2
cash-flows.row.sales-maturities-of-investments	11781.6	9442.2	5550.5	2215.3	3785	1604.2	775.6	544.6	274.5	327.4	476.4	378.1	439.2	426.4	276.6	297.4	646.9	527.2	306.2	223.4	277.9	253.3	215.8	124.2	53.7	83.2	93.5	75.9	38.9	38.8	61.3	68.5	82.8	61.8
cash-flows.row.other-investing-activites	-1793.9	0	-1026.8	-551.9	-614.6	-429.6	-1079.9	-732.6	-534.9	-229.7	-87.8	-199.1	-31.7	-0.3	1.1	0.1	-0.1	0	-1.6	0	0	0	0	0	0	0.1	-0.1	-0.1	0	0	0	-4.6	-0.9	-1.2
cash-flows.row.net-cash-used-for-investing-activites	-4636.5	-3185.1	-3784.6	-5384.7	-70.6	-2027.8	-1463	-1005.2	-1046.9	-907.6	-420.8	-355.5	-81.1	128.5	-434.2	0.1	30.8	-85.7	-155.1	115.5	-4.6	-63.8	-58.5	-75.4	-57.7	17.5	2.4	-38.9	-44.3	7.4	31.9	-23.6	8.2	-77.6
cash-flows.row.debt-repayment	0	0	0	0	-1500	0	0	-19.9	-40.6	-166.5	-221.7	-2	-2.2	-1.7	-1	0	-200.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	1342.4	1145.5	1519.5	1672.3	2575.2	211.8	114.5	240.2	126.7	206.4	126	57.4	63.5	18.5	196.8	8.6	7.9	319.4	185	4.1	1.5	94.7	2.1	158.5	94.4	1.4	0.5	43.4	70	23.2	0	51.1	0	91.6
cash-flows.row.common-stock-repurchased	-2419.2	-2935.6	-2528.5	-2678.1	-6527.6	-463.9	-191.6	-301.7	-143.2	-160.5	-267.6	-195.1	-163.3	0	0	0	0	0	0	0	-0.9	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	-358.7	-500.2	-547.5	-294.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-947.3	-700.6	-445.7	-1032.7	3481.9	-188	0	415.7	-143.2	405.3	448.6	216.9	4.3	367.4	47.5	22.8	0	0	0.4	0	3.8	13.5	-0.4	190.6	-1.5	-1.1	-1.9	-4	-3.7	-3.3	-0.2	-1.3	-0.8	-0.1
cash-flows.row.net-cash-used-provided-by-financing-activities	-1420.5	-1790.1	-1009	-1005.8	-1970.5	-252.1	-77.1	-24.4	-700.4	-262.8	-209.3	77.1	-97.6	384.2	243.3	31.4	-192.9	319.4	185.4	4.1	4.4	108.2	1.7	349.1	92.9	0.3	-1.4	39.4	66.3	19.9	-0.2	49.8	-0.8	91.5
cash-flows.row.effect-of-forex-changes-on-cash	3764.4	-0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-1319	-381.6	221.3	690.8	577	150.1	655	277.5	-273.9	160.4	113.1	305.3	-253.3	371	-94.5	-40.7	-251.1	261	53.4	89.3	-17.1	38.2	-167.3	216.4	7.3	3.9	-9.2	-5.6	1.7	9.1	11.2	-3.9	-9.8	7.1
cash-flows.row.cash-at-end-of-period	9449.7	2737.8	3119.4	2898.1	2207.3	1630.3	1480.2	812.7	535.2	809.1	648.7	535.6	230.3	483.6	112.6	207.1	247.8	498.9	237.9	184.5	101.2	118.3	80.1	247.4	31	23.7	19.7	28.9	34.4	32.7	23.7	12.5	16.4	26.3
cash-flows.row.cash-at-beginning-of-period	10768.7	3119.4	2898.1	2207.3	1630.3	1480.2	825.2	535.2	809.1	648.7	535.6	230.3	483.6	112.6	207.1	247.8	498.9	237.9	184.5	95.2	118.3	80.1	247.4	31	23.7	19.8	28.9	34.5	32.7	23.6	12.5	16.4	26.2	19.2
cash-flows.row.operating-cash-flow	4738.9	4594	5014.9	7081.3	2618.1	2430	2195.1	1307.1	1485.9	1330.8	752.4	588.6	-74.6	-141.7	96.3	-72.2	-89.1	27.4	23.1	-30.3	-16.9	-6.1	-110.5	-57.3	-27.9	-13.8	-10.2	-6.1	-20.3	-18.2	-20.5	-30.1	-17.2	-6.8
cash-flows.row.capital-expenditure	-764.3	-926.4	-590.1	-551.9	-614.6	-429.6	-383.1	-272.6	-511.9	-677.9	-333	-156.3	-49.3	-57.2	-99.7	-97.3	-34.9	-18.4	-2.8	-5	-6.2	-29.7	-34.4	-8.2	-6.5	-5.7	-3	-2.1	-8.6	-3.3	-6.9	-10.2	-2.1	-1
cash-flows.row.free-cash-flow	3974.6	3667.6	4424.8	6529.4	2003.5	2000.4	1812	1034.5	974	652.8	419.4	432.3	-124	-198.9	-3.3	-169.5	-123.9	8.9	20.3	-35.3	-23.1	-35.8	-144.9	-65.5	-34.4	-19.5	-13.2	-8.2	-28.9	-21.5	-27.4	-40.3	-19.3	-7.8

Resultatopgørelse række

Regeneron Pharmaceuticals, Inc.s omsætning oplevede en ændring på 0.078% sammenlignet med den foregående periode. Bruttofortjenesten for REGN rapporteres til at være 11301.4. Virksomhedens driftsomkostninger er 7068.2 og viser en ændring på 25.802% fra sidste år. Udgifterne til afskrivninger er 421, hvilket er en ændring på -0.031% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være 7068.2, hvilket viser en 25.802% ændring fra år til år. Salgs- og marketingomkostninger er 0, hvilket er en ændring på 0.000% sammenlignet med året før. EBITDA baseret på de seneste tal er 0, hvilket repræsenterer en -0.146% vækst i forhold til året før. Driftsindtægterne er 4047.1, som viser en ændring på -0.146% sammenlignet med året før. Ændringen i nettoindkomsten er -0.089%. Nettoindkomsten for det sidste år var 3953.6.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994	1992	1990
income-statement-row.row.total-revenue	13100.1	13117.2	12172.9	16071.7	8497.1	7863.4	6710.8	5872.2	4860.4	4103.7	2819.6	2104.7	1378.5	445.8	459.1	379.3	238.5	125	63.4	66.2	174	57.5	22	22	59.3	34.5	38.2	33.1	24.1	27.4	23.2	10.6	11.5	7.3	5
income-statement-row.row.cost-of-revenue	1681.7	1815.8	1560.4	2437.5	1119.9	782.2	434.1	397.1	299.7	392.7	205	155.4	84.5	4.2	2.1	1.7	0.9	0	8.1	9.6	15.2	6.7	6.5	6.5	15.6	3.6	5	2.6	1.1	0	0	0	0	12.8	6.3
income-statement-row.row.gross-profit	11418.4	11301.4	10612.5	13634.2	7377.2	7081.2	6276.7	5475.2	4560.7	3711	2614.5	1949.4	1294	441.6	457	377.6	237.5	125	55.3	56.6	158.8	50.8	15.5	15.5	43.7	30.9	33.2	30.5	23	27.4	23.2	10.6	11.5	-5.5	-1.3
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	4472.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	53.3	-20	-89.9	-45.6	-280.4	219.3	19.1	-1.1	-0.9	0	0	0	0	0	0	0	0	0	0	-248.8	0	0	0	0	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8	0.3
income-statement-row.row.operating-expenses	7205.5	7068.2	5618.5	4687.4	3800.6	4871.4	3742.3	3395.6	3230	2459.1	1776.1	1189.4	836.3	646.8	554.5	451.7	327.4	239.5	163	-67.8	153.2	150.8	137.5	101.1	69	54.7	45.8	38	40.3	35	52.4	49.4	29.8	4.1	2
income-statement-row.row.cost-and-expenses	8887.2	8884	7178.9	7124.9	4920.5	5653.6	4176.4	3792.6	3529.7	2851.8	1981.1	1344.7	920.8	651	556.5	453.4	328.3	239.5	171.1	-58.2	168.4	157.5	143.9	107.7	84.6	58.3	50.8	40.6	41.4	35	52.4	49.4	29.8	16.9	8.3
income-statement-row.row.interest-income	562.2	495.9	160.1	45.8	18.5	30.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	35.5	73	59.4	57.3	56.9	30.2	28.2	25.1	7.2	14.2	37.4	46.4	45.3	21.3	9.1	2.3	7.8	-20.9	-16.5	-41	-48.2	-4.5	-9.4	-12.2	4.6	-1	-4.4	3.4	14.3	14.7	0	0	0	-5.2	0
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	41.6	-456.8	119.9	379	233.8	219.3	19.1	-1.1	-0.9	-12.6	-25.3	-0.2	2	3.5	2.1	4.5	17.2	20.9	16.5	41	48.2	4.5	9.4	12.2	-4.6	1	4.4	-3.4	-14.3	-14.7	0	0	0	5.2	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	53.3	-20	-89.9	-45.6	-280.4	219.3	19.1	-1.1	-0.9	0	0	0	0	0	0	0	0	0	0	-248.8	0	0	0	0	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8	0.3
income-statement-row.row.total-operating-expenses	41.6	-456.8	119.9	379	233.8	219.3	19.1	-1.1	-0.9	-12.6	-25.3	-0.2	2	3.5	2.1	4.5	17.2	20.9	16.5	41	48.2	4.5	9.4	12.2	-4.6	1	4.4	-3.4	-14.3	-14.7	0	0	0	5.2	0
income-statement-row.row.interest-expense	35.5	73	59.4	57.3	56.9	30.2	28.2	25.1	7.2	14.2	37.4	46.4	45.3	21.3	9.1	2.3	7.8	-20.9	-16.5	-41	-48.2	-4.5	-9.4	-12.2	4.6	-1	-4.4	3.4	14.3	14.7	0	0	0	-5.2	0
income-statement-row.row.depreciation-and-amortization	435.6	421	434.4	436.3	290.7	210.3	148.2	145.5	104.7	74.9	52.7	41.2	36.9	31.1	19.7	14.2	11.3	11.5	14.6	15.5	15.4	12.9	8.5	6.1	4.4	3.4	3	4.4	6.1	5.9	4.2	3.1	2	0.8	0.3
income-statement-row.row.ebitda-caps	4452.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	3858.9	4047.1	4738.9	8946.8	3576.6	2209.8	2534.4	2079.6	1330.7	1251.9	838.4	760	457.7	-205.2	-97.5	-74.1	-89.8	-114.5	-107.7	124.4	5.6	-100	-122	-85.7	-25.3	-23.8	-12.6	-7.5	-17.3	-7.6	-29.2	-38.8	-18.3	-9.6	-3.3
income-statement-row.row.income-before-tax	4042	4199.3	4858.8	9325.8	3810.4	2429.1	2553.5	2078.5	1329.8	1225.1	775.7	713.4	414.4	-222.9	-104.5	-72	-80.4	-93.6	-91.1	124.4	53.9	-95.5	-112.5	-73.5	-29.9	-22.8	-8.2	-7.5	-17.3	-7.6	0	0	0	-4.4	0
income-statement-row.row.income-tax-expense	184.2	245.7	520.4	1250.5	297.2	313.3	109.1	880	434.3	589	427.7	289	-335.8	-1.1	-2.1	-4.1	2.4	-29.8	-21.9	178.8	-84.3	3	-7	-21.7	2.5	-1.7	-8.4	7.5	29.4	30.6	1.5	1.1	0.8	-10.3	0
income-statement-row.row.net-income	3857.8	3953.6	4338.4	8075.3	3513.2	2115.8	2444.4	1198.5	895.5	636.1	348.1	424.4	750.3	-221.8	-104.5	-67.8	-82.7	-105.6	-102.3	-95.4	41.7	-107.5	-124.4	-76.2	-23.2	-23.1	-8.6	-11.6	-32.4	-23.5	-30.7	-39.9	-19.1	-4.5	-3.3